Page 20 - The Conversation

Covid: Community spread to mutation, the risks if countries don't vaccinate

Some countries, such as Tanzania and Madagascar, have issued statements saying they do not have plans to vaccinate their populations against Covid-19

If Big Tech has the will, research can show the way to self-regulation

Research shows three key ways social media self-regulation can work: deprioritize engagement, label misinformation and crowdsource accuracy verification

How 'vaccine diplomacy' is helping some countries bolster their soft power

Vaccine diplomacy has also involved efforts to undermine trust in the intentions and efficacy of rival powers

China's spat with Jack Ma is bid to control big tech. Silicon Valley next?

Flagship changes like loosening merchant exclusivity might have had more impact several years ago, before competition intensified, but the direction of travel is clear

Cold supply chain challenge a big hurdle for equitable Covid-19 vaccination

The Pfizer and Moderna vaccines are a great start that should be celebrated, but they rely on a complicated supply chain of freezers and temperature-controlled shipping methods

World economy in 2021: Here's who will win and who will lose in Covid era

While America's 651 billionaires have increased their net worth by 30% to $4 trillion, a quarter of a billion people in developing countries could face absolute poverty

Covid-19 vaccine: A doctor answers 5 questions around rollout, distribution

Dr. Jason McKnight, a primary care physician at Texas A&M University, answers five questions about the rollout and distribution underway

It takes a lot of energy for machines to learn - Why AI is so power-hungry?

By some estimates, training an AI model generates as much carbon emissions as it takes to build and drive five cars over their lifetimes

Will going out in the cold give you a cold? Here is a reality check

Many viruses, including rhinovirus - the usual culprit in the common cold - and influenza, remain infectious longer and replicate faster in colder temperatures

Coronavirus mutation: Is the fear justified, and where does it come from?

Surely Hollywood must bear some responsibility for our misconceptions about mutation. After all, the concept has inspired movie makers for decades

What vaccine distribution planners can learn from Amazon and Walmart model

Fast fulfillment of uncertain demand is not unique to vaccine distribution. Amazon faces highly volatile demand for millions of products and yet is able to offer same-day and one-day delivery

The old and the new: Exploring Indian Ocean history on surface and in depth

The monsoon wind pattern makes the Indian Ocean relatively easy to cross both ways. In the Atlantic, by contrast, winds blow in one direction all year round

If not acted upon, Lunar gold rush could spark conflict on ground: Research

Many countries and private companies have ambitious plans to explore or mine the Moon

Net zero emissions targets are everywhere - we need to sort the genuine

The UK government has just published a ten-point plan for getting to net zero emissions, while the election of Joe Biden heralds a welcome change in the direction of US climate policy

It's not just you, work during coronavirus has become harder than before

The pandemic is increasingly understood as a shock, an event beyond our control that disrupted our normal ways of working and living

Here is why cities need to embrace the darkness of the night sky

Now, as England enters a second national lockdown, urban landscapes remain just as bright

Lessons from around the world on fighting coronavirus' second wave

Ten months into the pandemic, what have we learned and what other measures do we have in our collective toolkit?

Trump invitation to Michigan lawmakers could spark state political crisis

Michiganders voted 50.6% to 47.8% for Democrat Joe Biden over Trump

How sophisticated mRNA vaccines from Pfizer, Moderna are and how they work?

Pfizer-BioNTech vaccine candidate, BNT162b2, was 90% effective in preventing infection during the phase 3 clinical trial, which enrolled 43,538 participants, with 30% in U.S. and 42% abroad

New Yorkers knew Trump first - and spurned him before many Americans did

When Trump was elected in 2016, it was his first serious venture into electoral politics. In the half-century before his election, the then 70-year-old Trump had been a real estate developer